Effect of aspirin and celecoxib on Helicobacter pylori in vitro

Hui-Xia Ma,Wei-Hong Wang,Fu-Lian Hu,Jiang Li
DOI: https://doi.org/10.3969/j.issn.1009-3079.2006.28.002
2006-01-01
World Chinese Journal of Digestology
Abstract:AIM: To investigate the possible effects of aspirin and celecoxib on the growth, virulence factors and outer membrane protein of H pylori. METHODS: Two standard strains of H pylori were treated with a series concentration of aspirin or celecoxib (a specific inhibitor of cyclooxygenase 2) and were incubated in brucella broth under microaerobic condition for 24 and 48 h. The growth and urease activity were assessed by viable colony counting and spectrophotometry. After 48-hour treatment, the supernatants were incubated with Hela cells to estimate vacuolating cytotoxin activity. The outer membrane protein of H pylori was analyzed by SDS-PAGE. RESULTS: Aspirin or celecoxib inhibited the growth of H pylori in a dose-dependent manner with the lowest inhibitory concentrations of 0.5 or 0.01 mmol/L, and the lethal concentrations of 2.0 and 0.04 mmol/L, respectively. Aspirin and celecoxib inhibited the urease activity and vacuolating cytotoxin activity of H pylori. The inhibi tory effect of celecoxib on H pylori was superior to that of aspirin. Both aspirin and celecoxib had some effects on the expression of the outer membrane protein. CONCLUSION: Aspirin or celecoxib can inhibit the growth, urease activity and vacuolating cytotoxin activity of H pylori in vitro significantly. Both aspirin and celecoxib may have some effects on the outer membrane protein expression of H pylori.
What problem does this paper attempt to address?